A clinical trial at the HonorHealth Research Institute in Scottsdale is testing out new programming for pacemakers. A pacemaker is a device that treats slow heart rates with the use of electricity.
The clinical trial is for patients who require a pacemaker, but who no longer respond well to their current high blood pressure medication.
Dr. Rahul Doshi is an electrophysiologist in the Institute’s Cardiovascular Research Division. He said the new novel algorithm varies the timing between the upper and lower chambers in the heart to reduce hypertension.
“And we’re seeing if these results continue to hold up," Doshi said. "All the preliminary data that we have suggests that this technology works, it’s very simple, [and] patients tolerate it well.”
He added that getting a pacemaker is becoming a more common procedure as the population gets older and many of those patients have high blood pressure.
“This therapy works automatically without the patient or the doctor having to do anything," Doshi said. "You just turn it on, and it works."
For more information about HonorHealth Research Institute cardiovascular clinical trials, contact [email protected] or 480-323-1046.
-
On the last day of the Arizona State Fair this fall, Jenna Trybus’ 12-year-old daughter, Lucy, and her dad went — they rode some rides and visited the petting zoo. -
The ordinance would introduce regulations for unpaved country roads that see heavy machinery traffic in order to maintain air quality standards and limit dust emissions. -
The Arizona Hospital and Healthcare Association signed a letter in support of the funding application. Ann-Marie Alameddin, the group’s president and CEO, joined The Show to talk more. -
Americans are more likely to visit their eye doctor than their primary care provider. And that’s one big reason why a company out of California is working with Banner Alzheimer’s Institute in Arizona to develop an eye test that can detect beta amyloid in the retina. -
Researchers at the University of Arizona say a previously unknown population of circulating immune cells play a critical role in fibrosis. Blocking their signals could help treat or prevent the condition.
